EFFECTIVENESS OF LEVOCARNITINE IN CHILDREN WITH PPEUMONIA AGAINST THE BACKGROUND OF CARDITIS

Abstract

 Respiratory diseases are the most common group of diseases among children and occupy the first place in the structure of general morbidity in children. The relevance of chronic bronchopulmonary processes, disability and mortality remains. The aim of the study is to study the effectiveness of levocarnitine in pneumonia in children with carditis. Materials and methods of the study. The study included 56 children aged 1 to 10 years with pneumonia against the background of carditis, who received inpatient treatment in the pediatric departments and the pediatric intensive care unit of the Samarkand branch of the RRCEM. The patients were divided into 2 groups: Group I of 28 patients - children with pneumonia against the background of carditis, Group II of 28 patients - children with pneumonia. Sick children with pneumonia against the background of carditis were divided into 2 subgroups: Ia subgroup of 14 children who received standard therapy and Ib subgroup of 14 children who received oral levocarnitine in addition to standard therapy.